Ticabid 60mg Tablet
Marketer
Lupin Ltd
Salt Composition
Ticagrelor (60mg)
Overview Ticabid 60mg Tablet
CardioGuard 60mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of heart attack or stroke in individuals with cardiovascular conditions. CardioGuard 60mg tablets are also indicated for patients recovering from a recent heart attack, experiencing severe chest pain (unstable angina), or who have received cardiac stents. The medication helps prevent future cardiac events, including recurrent heart attacks, strokes, and clot formation within stents. Concomitant use with aspirin, another antiplatelet drug, is typically prescribed. CardioGuard 60mg tablets can be taken with or without food, consistently at the same time daily; uninterrupted use is crucial for efficacy. Discontinuing treatment increases the risk of recurrent heart attack or stroke. Increased bleeding is a common side effect; minor cuts or injuries may bleed longer than usual, though this typically resolves spontaneously. Mild shortness of breath may occur, usually subsiding with continued therapy. Report persistent bleeding, worsening or persistent shortness of breath to your physician. CardioGuard 60mg tablets are contraindicated in patients with active internal bleeding (e.g., stomach ulcers, cerebral hemorrhage) or liver disease. Disclose any such conditions to your doctor before commencing treatment.
Uses of Ticabid 60mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticabid 60mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 60mg Ticabid tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, though consistent timing is recommended.
Common Side effects of Ticabid 60mg Tablet:
- Bleeding
- Breathlessness
How to use Ticabid 60mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the 60mg Ticabid tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Ticabid 60mg Tablet works:
Aggrenox 60mg tablets are a medication that inhibits platelet aggregation. Their mechanism of action involves preventing platelet adhesion, thus reducing the likelihood of dangerous thrombus formation. This consequently minimizes the risk of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Ticabid 60mg tablets and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ticabid 60mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticabid 60mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticabid 60mg tablets.
KidneySAFE IF PRESCRIBED
Ticabid 60mg tablets are considered safe for individuals with kidney impairment, and no dosage modification is advised. Data regarding Ticabid 60mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticabid 60mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Ticabid 60mg tablet use; consult a physician for guidance.
What if you forget to take Ticabid 60mg Tablet :
Should you forget a Ticabid 60mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticabid 60mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |



